These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I. Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689 [Abstract] [Full Text] [Related]
3. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group. BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [Abstract] [Full Text] [Related]
4. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007. Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I. BJU Int; 2009 Oct; 104(7):954-9. PubMed ID: 19388983 [Abstract] [Full Text] [Related]
5. The economic impact of overactive bladder syndrome in six Western countries. Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C. BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532 [Abstract] [Full Text] [Related]
6. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. Teleman PM, Lidfeldt J, Nerbrand C, Samsioe G, Mattiasson A, WHILA study group. BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789 [Abstract] [Full Text] [Related]
7. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Malmsten UG, Molander U, Peeker R, Irwin DE, Milsom I. Eur Urol; 2010 Jul; 58(1):149-56. PubMed ID: 20356669 [Abstract] [Full Text] [Related]
8. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794 [Abstract] [Full Text] [Related]
9. The current and future burden and cost of overactive bladder in five European countries. Reeves P, Irwin D, Kelleher C, Milsom I, Kopp Z, Calvert N, Lloyd A. Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252 [Abstract] [Full Text] [Related]
10. The total economic burden of overactive bladder in the United States: a disease-specific approach. Onukwugha E, Zuckerman IH, McNally D, Coyne KS, Vats V, Mullins CD. Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803 [Abstract] [Full Text] [Related]
11. The wet patient: understanding patients with overactive bladder and incontinence. Serels S. Curr Med Res Opin; 2004 Jun; 20(6):791-801. PubMed ID: 15200735 [Abstract] [Full Text] [Related]
12. An epidemiological survey of overactive bladder symptoms in Japan. Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee. BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452 [Abstract] [Full Text] [Related]
13. Prevalence and burden of overactive bladder in the United States. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491 [Abstract] [Full Text] [Related]
14. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, Kang X. Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714 [Abstract] [Full Text] [Related]
15. Women overestimate daytime urinary frequency: the importance of the bladder diary. Stav K, Dwyer PL, Rosamilia A. J Urol; 2009 May; 181(5):2176-80. PubMed ID: 19296975 [Abstract] [Full Text] [Related]
16. Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women. McGrother CW, Donaldson MM, Hayward T, Matthews R, Dallosso HM, Hyde C, Leicestershire MRC Incontinence Study Team. Age Ageing; 2006 Jan; 35(1):16-24. PubMed ID: 16234314 [Abstract] [Full Text] [Related]
17. Incidence and remission of lower urinary tract symptoms during 12 years after the first delivery: a cohort study. Viktrup L, Lose G. J Urol; 2008 Sep; 180(3):992-7. PubMed ID: 18639264 [Abstract] [Full Text] [Related]
19. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T. Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704 [Abstract] [Full Text] [Related]
20. Prevalence of overactive bladder and incontinence in Canada. Corcos J, Schick E. Can J Urol; 2004 Jun; 11(3):2278-84. PubMed ID: 15287994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]